Anebulo Pharmaceuticals
ANEB
ANEB
11 hedge funds and large institutions have $19.2M invested in Anebulo Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+2
Holders Change %
+22.22%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
3
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
2L
22NW LP
Seattle,
Washington
|
$14.2M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
$1.43M |
| 3 |
Morgan Stanley
New York
|
$2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
$21K |
Top Sellers
| 1 |
LA
LVW Advisors
Pittsford,
New York
|
$1.89M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
$437K |
| 3 |
BlackRock
New York
|
$20K |
| 4 |
UBS Group
Zurich,
Switzerland
|
$8K |
| 5 |
BFM
Boothbay Fund Management
New York
|
$48K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
2L
1
22NW LP
Seattle,
Washington
| $14.2M | +$4.77M | +1,703,577 | +51% |
|
|
LA
2
LVW Advisors
Pittsford,
New York
| $1.89M | -$70.1K | -25,036 | -4% |
|
|
NCM
3
Nantahala Capital Management
New Canaan,
Connecticut
| $1.43M | +$1.43M | +511,073 | New |
|
|
MP
4
Mangrove Partners
Greenwich,
Connecticut
| $1.12M | – | – | – |
|
|
IC
5
Ikarian Capital
Dallas,
Texas
| $437K | -$69.9K | -24,996 | -14% |
|
|
BFM
6
Boothbay Fund Management
New York
| $48K | -$39 | -14 | -0.1% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $21K | +$541 | +189 | +3% |
|
|
8
BlackRock
New York
| $20K | -$561 | -200 | -3% |
|
|
9
UBS Group
Zurich,
Switzerland
| $8K | -$368 | -128 | -4% |
|
|
10
Morgan Stanley
New York
| $2K | +$2K | +600 | New |
|